BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 15570675)

  • 1. Drug labeling; sodium labeling for over-the-counter drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Nov; 69(228):69278-80. PubMed ID: 15570675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final rule for over-the-counter antitussive drug products; technical amendment. Final rule, technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Nov; 72(230):67639-40. PubMed ID: 18064767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(33):7919-21. PubMed ID: 12593411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin protectant drug products for over-the-counter human use; astringent drug products; final monograph; direct final rule. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(114):35290-3. PubMed ID: 12807133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Feb; 67(27):5942-3. PubMed ID: 11837282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiarrheal drug products for over-the-counter human use; amendment of final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 May; 69(92):26301-2. PubMed ID: 15141675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ingrown toenail relief drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 May; 68(88):24347-9. PubMed ID: 12737160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(110):34273-93. PubMed ID: 12795305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for over-the-counter nasal decongestant drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(195):58974-7. PubMed ID: 16217879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of monograph for OTC nasal decongestant drug products. Final rule.
    Fed Regist; 2006 Aug; 71(147):83358[sic., should be 43358]-63. PubMed ID: 16892519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin protectant drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(236):68509-11. PubMed ID: 14664244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laxative drug products for over-the-counter human use; psyllium ingredients in granular dosage forms. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Mar; 72(60):14669-74. PubMed ID: 17450664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(250):75414-8. PubMed ID: 14986677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye's Syndrome warning. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Apr; 68(74):18861-9. PubMed ID: 12701599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 May; 67(90):31125-7. PubMed ID: 12001972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 May; 67(90):31123-5. PubMed ID: 12001971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 May; 64(98):27666-93. PubMed ID: 10558542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Jan; 64(19):4535-40. PubMed ID: 10557608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.